GrippeEspagneV1, Main, Exploration, bibRecord, 000491

Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.

Identifieur interne : 000491 ( Main/Exploration ); précédent : 000490; suivant : 000492

Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.

Auteurs : Melchor Riera [Espagne] ; Antoni Payeras ; Maria A. Marcos ; Diego Viasus ; Maria C. Farinas ; Ferran Segura ; Julian Torre-Cisneros ; Alejandro Martín-Quir S ; Jesús Rodríguez-Ba O ; Juan Vila ; Elisa Cordero ; Jordi Carratalà

Source :

AIDS (London, England) [ 1473-5571 ] ; 2010.

RBID : pubmed:20827165

Descripteurs français

KwdFr :
- Adulte (MeSH), Charge virale (immunologie), Espagne (épidémiologie), Femelle (MeSH), Grippe humaine (complications), Grippe humaine (immunologie), Grippe humaine (traitement médicamenteux), Hospitalisation (statistiques et données numériques), Humains (MeSH), Infections à VIH (complications), Infections à VIH (immunologie), Infections à VIH (traitement médicamenteux), Mâle (MeSH), Numération des lymphocytes CD4 (MeSH), Pronostic (MeSH), Sous-type H1N1 du virus de la grippe A (immunologie), Sous-type H1N1 du virus de la grippe A (pathogénicité), Thérapie antirétrovirale hautement active (MeSH), VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie), Vaccins antigrippaux (MeSH), Études prospectives (MeSH).
MESH :
- immunologie : Charge virale, Grippe humaine, Infections à VIH, Sous-type H1N1 du virus de la grippe A, VIH-1 (Virus de l'Immunodéficience Humaine de type 1).
- pathogénicité : Sous-type H1N1 du virus de la grippe A.
- statistiques et données numériques : Hospitalisation.
- traitement médicamenteux : Grippe humaine, Infections à VIH.
- épidémiologie : Espagne, Grippe humaine, Infections à VIH.
- Adulte, Femelle, Humains, Mâle, Numération des lymphocytes CD4, Pronostic, Thérapie antirétrovirale hautement active, Vaccins antigrippaux, Études prospectives.
Wicri :
- geographic : Espagne.

English descriptors

KwdEn :
- Adult (MeSH), Antiretroviral Therapy, Highly Active (MeSH), CD4 Lymphocyte Count (MeSH), Female (MeSH), HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (immunology), HIV-1 (immunology), Hospitalization (statistics & numerical data), Humans (MeSH), Influenza A Virus, H1N1 Subtype (immunology), Influenza A Virus, H1N1 Subtype (pathogenicity), Influenza Vaccines (MeSH), Influenza, Human (complications), Influenza, Human (drug therapy), Influenza, Human (immunology), Male (MeSH), Prognosis (MeSH), Prospective Studies (MeSH), Spain (epidemiology), Viral Load (immunology).
MESH :
- chemical : Influenza Vaccines.
- geographic , epidemiology : Spain.
- complications : HIV Infections, Influenza, Human.
- drug therapy : HIV Infections, Influenza, Human.
- immunology : HIV Infections, HIV-1, Influenza A Virus, H1N1 Subtype, Influenza, Human, Viral Load.
- pathogenicity : Influenza A Virus, H1N1 Subtype.
- statistics & numerical data : Hospitalization.
- Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Female, Humans, Male, Prognosis, Prospective Studies.

Abstract

OBJECTIVE

The aim of the study was to describe the clinical presentation and prognosis in HIV-1-infected patients with hospital admission and pandemic influenza A 2009 (H1N1) confirmed, and compare this data with those of a general population.

DESIGN

: This is a prospective study in nature.

METHODS

All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009(H1N1) virus infection by real-time reverse transcriptase PCR assay or culture from June 12 to November 10, 2009 were recruited and followed up until 1 month after discharge. In the HIV group risk factors for HIV infection, AIDS criteria, last CD4 cell count and viral load, and antiretroviral therapy and pneumococcal vaccines were collected.

RESULTS

Five hundred and eighty-five patients were recruited, 26 with HIV-1 infection and 559 non-HIV. The HIV patients had a long-term well controlled infection with a median CD4 cell count 503 cells/μl and 84% with undetectable viral load, although more frequently they had chronic liver and chronic obstructive pulmonary disease. No significant differences were observed about reported symptoms and physical findings on hospital admission. About 50% of patients in both groups present radiological infiltrates and 30% present respiratory failures. Practically all the patients in both groups received influenza antiviral therapy and in each group 80% received antibacterial therapy. No differences were observed in clinical outcomes.

CONCLUSION

In HIV patients, well controlled on HAART, the pandemic influenza virus AH1N1 had a similar clinical outcome and prognosis to that of non-HIV patients.

DOI: 10.1097/QAD.0b013e32833e508f
PubMed: 20827165

Affiliations:

Espagne

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 00444
to stream Main, to step Curation: 000444

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.</title>
<author><name sortKey="Riera, Melchor" sort="Riera, Melchor" uniqKey="Riera M" first="Melchor" last="Riera">Melchor Riera</name>
<affiliation wicri:level="1"><nlm:affiliation>Palma De Mallorca, Hospital Son Dureta, Spain. melchor.riera@ssib.es</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Palma De Mallorca, Hospital Son Dureta</wicri:regionArea>
<wicri:noRegion>Hospital Son Dureta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Payeras, Antoni" sort="Payeras, Antoni" uniqKey="Payeras A" first="Antoni" last="Payeras">Antoni Payeras</name>
</author>
<author><name sortKey="Marcos, Maria A" sort="Marcos, Maria A" uniqKey="Marcos M" first="Maria A" last="Marcos">Maria A. Marcos</name>
</author>
<author><name sortKey="Viasus, Diego" sort="Viasus, Diego" uniqKey="Viasus D" first="Diego" last="Viasus">Diego Viasus</name>
</author>
<author><name sortKey="Farinas, Maria C" sort="Farinas, Maria C" uniqKey="Farinas M" first="Maria C" last="Farinas">Maria C. Farinas</name>
</author>
<author><name sortKey="Segura, Ferran" sort="Segura, Ferran" uniqKey="Segura F" first="Ferran" last="Segura">Ferran Segura</name>
</author>
<author><name sortKey="Torre Cisneros, Julian" sort="Torre Cisneros, Julian" uniqKey="Torre Cisneros J" first="Julian" last="Torre-Cisneros">Julian Torre-Cisneros</name>
</author>
<author><name sortKey="Martin Quir S, Alejandro" sort="Martin Quir S, Alejandro" uniqKey="Martin Quir S A" first="Alejandro" last="Martín-Quir S">Alejandro Martín-Quir S</name>
</author>
<author><name sortKey="Rodriguez Ba O, Jesus" sort="Rodriguez Ba O, Jesus" uniqKey="Rodriguez Ba O J" first="Jesús" last="Rodríguez-Ba O">Jesús Rodríguez-Ba O</name>
</author>
<author><name sortKey="Vila, Juan" sort="Vila, Juan" uniqKey="Vila J" first="Juan" last="Vila">Juan Vila</name>
</author>
<author><name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name>
</author>
<author><name sortKey="Carratala, Jordi" sort="Carratala, Jordi" uniqKey="Carratala J" first="Jordi" last="Carratalà">Jordi Carratalà</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20827165</idno>
<idno type="pmid">20827165</idno>
<idno type="doi">10.1097/QAD.0b013e32833e508f</idno>
<idno type="wicri:Area/Main/Corpus">00444</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00444</idno>
<idno type="wicri:Area/Main/Curation">000444</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000444</idno>
<idno type="wicri:Area/Main/Exploration">000444</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.</title>
<author><name sortKey="Riera, Melchor" sort="Riera, Melchor" uniqKey="Riera M" first="Melchor" last="Riera">Melchor Riera</name>
<affiliation wicri:level="1"><nlm:affiliation>Palma De Mallorca, Hospital Son Dureta, Spain. melchor.riera@ssib.es</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Palma De Mallorca, Hospital Son Dureta</wicri:regionArea>
<wicri:noRegion>Hospital Son Dureta</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Payeras, Antoni" sort="Payeras, Antoni" uniqKey="Payeras A" first="Antoni" last="Payeras">Antoni Payeras</name>
</author>
<author><name sortKey="Marcos, Maria A" sort="Marcos, Maria A" uniqKey="Marcos M" first="Maria A" last="Marcos">Maria A. Marcos</name>
</author>
<author><name sortKey="Viasus, Diego" sort="Viasus, Diego" uniqKey="Viasus D" first="Diego" last="Viasus">Diego Viasus</name>
</author>
<author><name sortKey="Farinas, Maria C" sort="Farinas, Maria C" uniqKey="Farinas M" first="Maria C" last="Farinas">Maria C. Farinas</name>
</author>
<author><name sortKey="Segura, Ferran" sort="Segura, Ferran" uniqKey="Segura F" first="Ferran" last="Segura">Ferran Segura</name>
</author>
<author><name sortKey="Torre Cisneros, Julian" sort="Torre Cisneros, Julian" uniqKey="Torre Cisneros J" first="Julian" last="Torre-Cisneros">Julian Torre-Cisneros</name>
</author>
<author><name sortKey="Martin Quir S, Alejandro" sort="Martin Quir S, Alejandro" uniqKey="Martin Quir S A" first="Alejandro" last="Martín-Quir S">Alejandro Martín-Quir S</name>
</author>
<author><name sortKey="Rodriguez Ba O, Jesus" sort="Rodriguez Ba O, Jesus" uniqKey="Rodriguez Ba O J" first="Jesús" last="Rodríguez-Ba O">Jesús Rodríguez-Ba O</name>
</author>
<author><name sortKey="Vila, Juan" sort="Vila, Juan" uniqKey="Vila J" first="Juan" last="Vila">Juan Vila</name>
</author>
<author><name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name>
</author>
<author><name sortKey="Carratala, Jordi" sort="Carratala, Jordi" uniqKey="Carratala J" first="Jordi" last="Carratalà">Jordi Carratalà</name>
</author>
</analytic>
<series><title level="j">AIDS (London, England)</title>
<idno type="eISSN">1473-5571</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Antiretroviral Therapy, Highly Active (MeSH)</term>
<term>CD4 Lymphocyte Count (MeSH)</term>
<term>Female (MeSH)</term>
<term>HIV Infections (complications)</term>
<term>HIV Infections (drug therapy)</term>
<term>HIV Infections (immunology)</term>
<term>HIV-1 (immunology)</term>
<term>Hospitalization (statistics & numerical data)</term>
<term>Humans (MeSH)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H1N1 Subtype (pathogenicity)</term>
<term>Influenza Vaccines (MeSH)</term>
<term>Influenza, Human (complications)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (immunology)</term>
<term>Male (MeSH)</term>
<term>Prognosis (MeSH)</term>
<term>Prospective Studies (MeSH)</term>
<term>Spain (epidemiology)</term>
<term>Viral Load (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term>
<term>Charge virale (immunologie)</term>
<term>Espagne (épidémiologie)</term>
<term>Femelle (MeSH)</term>
<term>Grippe humaine (complications)</term>
<term>Grippe humaine (immunologie)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Hospitalisation (statistiques et données numériques)</term>
<term>Humains (MeSH)</term>
<term>Infections à VIH (complications)</term>
<term>Infections à VIH (immunologie)</term>
<term>Infections à VIH (traitement médicamenteux)</term>
<term>Mâle (MeSH)</term>
<term>Numération des lymphocytes CD4 (MeSH)</term>
<term>Pronostic (MeSH)</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H1N1 du virus de la grippe A (pathogénicité)</term>
<term>Thérapie antirétrovirale hautement active (MeSH)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term>
<term>Vaccins antigrippaux (MeSH)</term>
<term>Études prospectives (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Spain</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term>
<term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Charge virale</term>
<term>Grippe humaine</term>
<term>Infections à VIH</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term>
<term>HIV-1</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza, Human</term>
<term>Viral Load</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Hospitalisation</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Espagne</term>
<term>Grippe humaine</term>
<term>Infections à VIH</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Antiretroviral Therapy, Highly Active</term>
<term>CD4 Lymphocyte Count</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Prognosis</term>
<term>Prospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Numération des lymphocytes CD4</term>
<term>Pronostic</term>
<term>Thérapie antirétrovirale hautement active</term>
<term>Vaccins antigrippaux</term>
<term>Études prospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b>
</p>
<p>The aim of the study was to describe the clinical presentation and prognosis in HIV-1-infected patients with hospital admission and pandemic influenza A 2009 (H1N1) confirmed, and compare this data with those of a general population.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>DESIGN</b>
</p>
<p>: This is a prospective study in nature.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009(H1N1) virus infection by real-time reverse transcriptase PCR assay or culture from June 12 to November 10, 2009 were recruited and followed up until 1 month after discharge. In the HIV group risk factors for HIV infection, AIDS criteria, last CD4 cell count and viral load, and antiretroviral therapy and pneumococcal vaccines were collected.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Five hundred and eighty-five patients were recruited, 26 with HIV-1 infection and 559 non-HIV. The HIV patients had a long-term well controlled infection with a median CD4 cell count 503 cells/μl and 84% with undetectable viral load, although more frequently they had chronic liver and chronic obstructive pulmonary disease. No significant differences were observed about reported symptoms and physical findings on hospital admission. About 50% of patients in both groups present radiological infiltrates and 30% present respiratory failures. Practically all the patients in both groups received influenza antiviral therapy and in each group 80% received antibacterial therapy. No differences were observed in clinical outcomes.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSION</b>
</p>
<p>In HIV patients, well controlled on HAART, the pandemic influenza virus AH1N1 had a similar clinical outcome and prognosis to that of non-HIV patients.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20827165</PMID>
<DateCompleted><Year>2011</Year>
<Month>03</Month>
<Day>25</Day>
</DateCompleted>
<DateRevised><Year>2010</Year>
<Month>10</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-5571</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>16</Issue>
<PubDate><Year>2010</Year>
<Month>Oct</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>AIDS (London, England)</Title>
<ISOAbbreviation>AIDS</ISOAbbreviation>
</Journal>
<ArticleTitle>Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.</ArticleTitle>
<Pagination><MedlinePgn>2461-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/QAD.0b013e32833e508f</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of the study was to describe the clinical presentation and prognosis in HIV-1-infected patients with hospital admission and pandemic influenza A 2009 (H1N1) confirmed, and compare this data with those of a general population.</AbstractText>
<AbstractText Label="DESIGN" NlmCategory="METHODS">: This is a prospective study in nature.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009(H1N1) virus infection by real-time reverse transcriptase PCR assay or culture from June 12 to November 10, 2009 were recruited and followed up until 1 month after discharge. In the HIV group risk factors for HIV infection, AIDS criteria, last CD4 cell count and viral load, and antiretroviral therapy and pneumococcal vaccines were collected.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Five hundred and eighty-five patients were recruited, 26 with HIV-1 infection and 559 non-HIV. The HIV patients had a long-term well controlled infection with a median CD4 cell count 503 cells/μl and 84% with undetectable viral load, although more frequently they had chronic liver and chronic obstructive pulmonary disease. No significant differences were observed about reported symptoms and physical findings on hospital admission. About 50% of patients in both groups present radiological infiltrates and 30% present respiratory failures. Practically all the patients in both groups received influenza antiviral therapy and in each group 80% received antibacterial therapy. No differences were observed in clinical outcomes.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In HIV patients, well controlled on HAART, the pandemic influenza virus AH1N1 had a similar clinical outcome and prognosis to that of non-HIV patients.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Riera</LastName>
<ForeName>Melchor</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Palma De Mallorca, Hospital Son Dureta, Spain. melchor.riera@ssib.es</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Payeras</LastName>
<ForeName>Antoni</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Marcos</LastName>
<ForeName>Maria A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Viasus</LastName>
<ForeName>Diego</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Farinas</LastName>
<ForeName>Maria C</ForeName>
<Initials>MC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Segura</LastName>
<ForeName>Ferran</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Torre-Cisneros</LastName>
<ForeName>Julian</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Martín-Quirós</LastName>
<ForeName>Alejandro</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rodríguez-Baño</LastName>
<ForeName>Jesús</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vila</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cordero</LastName>
<ForeName>Elisa</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Carratalà</LastName>
<ForeName>Jordi</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>AIDS</MedlineTA>
<NlmUniqueID>8710219</NlmUniqueID>
<ISSNLinking>0269-9370</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D023241" MajorTopicYN="N">Antiretroviral Therapy, Highly Active</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018791" MajorTopicYN="N">CD4 Lymphocyte Count</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
<QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>9</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>9</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>3</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20827165</ArticleId>
<ArticleId IdType="doi">10.1097/QAD.0b013e32833e508f</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
</list>
<tree><noCountry><name sortKey="Carratala, Jordi" sort="Carratala, Jordi" uniqKey="Carratala J" first="Jordi" last="Carratalà">Jordi Carratalà</name>
<name sortKey="Cordero, Elisa" sort="Cordero, Elisa" uniqKey="Cordero E" first="Elisa" last="Cordero">Elisa Cordero</name>
<name sortKey="Farinas, Maria C" sort="Farinas, Maria C" uniqKey="Farinas M" first="Maria C" last="Farinas">Maria C. Farinas</name>
<name sortKey="Marcos, Maria A" sort="Marcos, Maria A" uniqKey="Marcos M" first="Maria A" last="Marcos">Maria A. Marcos</name>
<name sortKey="Martin Quir S, Alejandro" sort="Martin Quir S, Alejandro" uniqKey="Martin Quir S A" first="Alejandro" last="Martín-Quir S">Alejandro Martín-Quir S</name>
<name sortKey="Payeras, Antoni" sort="Payeras, Antoni" uniqKey="Payeras A" first="Antoni" last="Payeras">Antoni Payeras</name>
<name sortKey="Rodriguez Ba O, Jesus" sort="Rodriguez Ba O, Jesus" uniqKey="Rodriguez Ba O J" first="Jesús" last="Rodríguez-Ba O">Jesús Rodríguez-Ba O</name>
<name sortKey="Segura, Ferran" sort="Segura, Ferran" uniqKey="Segura F" first="Ferran" last="Segura">Ferran Segura</name>
<name sortKey="Torre Cisneros, Julian" sort="Torre Cisneros, Julian" uniqKey="Torre Cisneros J" first="Julian" last="Torre-Cisneros">Julian Torre-Cisneros</name>
<name sortKey="Viasus, Diego" sort="Viasus, Diego" uniqKey="Viasus D" first="Diego" last="Viasus">Diego Viasus</name>
<name sortKey="Vila, Juan" sort="Vila, Juan" uniqKey="Vila J" first="Juan" last="Vila">Juan Vila</name>
</noCountry>
<country name="Espagne"><noRegion><name sortKey="Riera, Melchor" sort="Riera, Melchor" uniqKey="Riera M" first="Melchor" last="Riera">Melchor Riera</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000491 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000491 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeEspagneV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:20827165
   |texte=   Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20827165" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeEspagneV1

This area was generated with Dilib version V0.6.37.
Data generation: Fri Sep 25 11:01:38 2020. Site generation: Sat Feb 13 17:38:04 2021

	Serveur d'exploration sur la grippe en Espagne
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe en Espagne

Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.

Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki